Video

Treating agitation in schizophrenia

Current Psychiatry. 2016 November;15(11)
By
Leslie L. Citrome
MD
Mph
Author and Disclosure Information

Leslie L. Citrome, MD, MPH, describes using intramuscular, sublingual, and inhaled formulations of antipsychotics to treat agitation in schizophrenia

 

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

Recommended Reading

FDA adds lurasidone contraindication to HIV drug labels
MDedge Psychiatry
Psychiatric risks quantified in siblings of mental disorder patients
MDedge Psychiatry
Experts offer tips on anxiety, depression, and psychosis in Parkinson’s
MDedge Psychiatry
‘They’re out to get me!’: Evaluating rational fears and bizarre delusions in paranoia
MDedge Psychiatry
Rediscovering clozapine: Clinically relevant off-label uses
MDedge Psychiatry
Stabilized schizoaffective disorder; later confusion and depression appears
MDedge Psychiatry
Cannabis use after first-episode psychosis may raise relapse risk
MDedge Psychiatry
Cariprazine shows efficacy for schizophrenia’s negative symptoms
MDedge Psychiatry
‘Committed’ takes a nonpatronizing approach to involuntary care
MDedge Psychiatry
Recognizing anti-NMDA receptor encephalitis psychosis on the psych ward
MDedge Psychiatry